Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer

Estrogen receptor α (ERα) is expressed in ~67% of breast cancers and is critical to their proliferation and progression. The expression of ERα is regarded as a major prognostic marker, making it a meaningful target to treat breast cancer (BCa). However, hormone receptor-positive BCa was sometimes ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Xiaohong, Liao, Yuning, Guo, Zhiqiang, Li, Yanling, Jiang, Lili, Zhang, Fangcheng, Huang, Chuyi, Liu, Yuan, Wang, Xuejun, Liu, Ningning, Liu, Jinbao, Huang, Hongbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155249/
https://www.ncbi.nlm.nih.gov/pubmed/30250021
http://dx.doi.org/10.1038/s41389-018-0086-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155249/
https://www.ncbi.nlm.nih.gov/pubmed/30250021
http://dx.doi.org/10.1038/s41389-018-0086-y

Ejemplares similares